These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31573335)

  • 21. MUC5B: a good target for future therapy in pulmonary fibrosis?
    Mahida R; Turner AM
    Thorax; 2013 May; 68(5):401. PubMed ID: 23329274
    [No Abstract]   [Full Text] [Related]  

  • 22. XBP1S Regulates MUC5B in a Promoter Variant-Dependent Pathway in Idiopathic Pulmonary Fibrosis Airway Epithelia.
    Chen G; Ribeiro CMP; Sun L; Okuda K; Kato T; Gilmore RC; Martino MB; Dang H; Abzhanova A; Lin JM; Hull-Ryde EA; Volmer AS; Randell SH; Livraghi-Butrico A; Deng Y; Scherer PE; Stripp BR; O'Neal WK; Boucher RC
    Am J Respir Crit Care Med; 2019 Jul; 200(2):220-234. PubMed ID: 30973754
    [No Abstract]   [Full Text] [Related]  

  • 23. A common MUC5B promoter polymorphism and pulmonary fibrosis.
    Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
    N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is top of the charts? BPIFB1/LPLUNC1 localises to the bronchiolised epithelium in the honeycomb cysts in UIP.
    Bingle CD; Araujo B; Wallace WA; Hirani N; Bingle L
    Thorax; 2013 Dec; 68(12):1167-8. PubMed ID: 24014631
    [No Abstract]   [Full Text] [Related]  

  • 25. The
    Platenburg MGJP; Wiertz IA; van der Vis JJ; Crestani B; Borie R; Dieude P; Kannengiesser C; Burgers JA; Grutters JC; van Moorsel CHM
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 31949121
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
    Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
    Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.
    Polosukhin VV; Degryse AL; Newcomb DC; Jones BR; Ware LB; Lee JW; Loyd JE; Blackwell TS; Lawson WE
    Exp Lung Res; 2012 Apr; 38(3):135-46. PubMed ID: 22394287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleomycin revisited: towards a more representative model of IPF?
    Scotton CJ; Chambers RC
    Am J Physiol Lung Cell Mol Physiol; 2010 Oct; 299(4):L439-41. PubMed ID: 20675435
    [No Abstract]   [Full Text] [Related]  

  • 29. MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis.
    Dhooria S; Bal A; Sehgal IS; Prasad KT; Kashyap D; Sharma R; Muthu V; Agarwal R; Aggarwal AN
    Chest; 2022 Oct; 162(4):824-827. PubMed ID: 35405109
    [No Abstract]   [Full Text] [Related]  

  • 30. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current progression in the biomarkers of idiopathic pulmonary fibrosis].
    Wang XF; Zhang YW; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):841-3. PubMed ID: 24507397
    [No Abstract]   [Full Text] [Related]  

  • 32. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
    Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
    EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.
    Kulkarni HS; Guzy RD; McEvoy C
    Am J Respir Crit Care Med; 2014 May; 189(9):1138-40. PubMed ID: 24787067
    [No Abstract]   [Full Text] [Related]  

  • 35. Idiopathic pulmonary fibrosis--a sticky business.
    Boucher RC
    N Engl J Med; 2011 Apr; 364(16):1560-1. PubMed ID: 21506745
    [No Abstract]   [Full Text] [Related]  

  • 36. MUC5B expression and location in surfactant protein C mutations in children.
    Liptzin DR; Watson AM; Murphy E; Kroehl ME; Dishop MK; Galambos C; Evans CM; Schwarz MI; Deterding RR; Schwartz DA
    Pediatr Pulmonol; 2015 Dec; 50(12):1270-6. PubMed ID: 25858779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course.
    Kumar A; Dougherty M; Findlay GM; Geisheker M; Klein J; Lazar J; Machkovech H; Resnick J; Resnick R; Salter AI; Talebi-Liasi F; Arakawa C; Baudin J; Bogaard A; Salesky R; Zhou Q; Smith K; Clark JI; Shendure J; Horwitz MS
    PLoS One; 2014; 9(9):e106744. PubMed ID: 25192356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.
    Peng R; Sridhar S; Tyagi G; Phillips JE; Garrido R; Harris P; Burns L; Renteria L; Woods J; Chen L; Allard J; Ravindran P; Bitter H; Liang Z; Hogaboam CM; Kitson C; Budd DC; Fine JS; Bauer CM; Stevenson CS
    PLoS One; 2013; 8(4):e59348. PubMed ID: 23565148
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Mathai SK; Humphries S; Kropski JA; Blackwell TS; Powers J; Walts AD; Markin C; Woodward J; Chung JH; Brown KK; Steele MP; Loyd JE; Schwarz MI; Fingerlin T; Yang IV; Lynch DA; Schwartz DA
    Thorax; 2019 Dec; 74(12):1131-1139. PubMed ID: 31558622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.